Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Price:
0.0574 USD
-7.42%
Updated:
May 20, 2024
Aridis Pharmaceuticals Inc
Net Change in Cash
|
Aridis Pharmaceuticals Inc
Net Change in Cash Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
|
Net Change in Cash
-$14.4m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Change in Cash
$11.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Change in Cash
-$218m
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Change in Cash
-$21.9B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
-56%
|
CAGR 10-Years
N/A
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Change in Cash
-$126.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Change in Cash
-$1.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Aridis Pharmaceuticals Inc's Net Change in Cash?
Net Change in Cash
-14.4m
USD
-14.4m
USD
Based on the financial report for Dec 31, 2022, Aridis Pharmaceuticals Inc's Net Change in Cash amounts to -14.4m USD.
What is Aridis Pharmaceuticals Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-63%
-63%
The average annual Net Change in Cash growth rates for Aridis Pharmaceuticals Inc have been -63% over the past three years .
You don't have any saved screeners yet
